ZNN Bactiguard Retrograde Femoral Nails PMCF Study
← catalyst calendarNCT05276674 · readout ≤ 499 d
Sponsored by Zimmer Biomet (industry) · ZBH — their whole pipeline →.
Phase
—
Status
Recruiting
Study type
Observational
Enrollment
100estimated
Sites
4
Countries
Spain, United Kingdom
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2023-10-23 | actual | When the study began enrolling |
| Primary completion | Dec 2027 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | Dec 2027 | estimated | The whole study's end, after follow-up |
| First posted | 2022-03-11 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-02-03 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Femoral Fracture
Intervention
- Device: ZNN Bactiguard Retrograde Femoral Nail
Primary outcome
what the primary-completion date above is the date OFRate of fracture healing 12 months after fracture fixation
measured 3, 6, and 12 months after fracture fixation
Permalink · ZBH's whole pipeline · Catalyst calendar · Every registered study · What changed